| Q46346112 | A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. |
| Q37623067 | Bench-to-bedside review: Beta-adrenergic modulation in sepsis. |
| Q37781413 | Bench-to-bedside review: Glucose and stress conditions in the intensive care unit |
| Q53429472 | Dynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation. |
| Q42857128 | Increased FGF21 plasma levels in humans with sepsis and SIRS. |
| Q42322399 | LPS infusion suppresses serum FGF21 levels in healthy adult volunteers |
| Q55432566 | Levels and Diagnostic Value of Model-based Insulin Sensitivity in Sepsis: A Preliminary Study. |
| Q49359468 | Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial |
| Q42598514 | Model-based insulin sensitivity as a sepsis diagnostic in critical care |
| Q37626450 | Parenteral glucose and glucose control in the critically ill: a kinetic appraisal |
| Q99724685 | Physiologic Effects of Exogenous Dextrose in Murine Klebsiella pneumoniae Sepsis Vary by Route of Provision |
| Q33916541 | Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. |
| Q26998504 | Response to trauma and metabolic changes: posttraumatic metabolism |
| Q35678350 | Stress-hyperglycemia, insulin and immunomodulation in sepsis |
| Q24317321 | The acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways |
| Q89397680 | The impact of immobilisation and inflammation on the regulation of muscle mass and insulin resistance: different routes to similar end-points |